POPULATION PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) MODELING FOR AN ANTISENSE OLIGONUCLEOTIDE (ISIS-FXIRx), TARGETING FACTOR XI, IN HEALTHY SUBJECTS.

Yu R.; Luu K.; Bethune C.; Bhanot S.; Liu Q.; Wang Y.

首页> 外文期刊>Clinical Pharmacology and Therapeutics >POPULATION PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) MODELING FOR AN ANTISENSE OLIGONUCLEOTIDE (ISIS-FXIRx), TARGETING FACTOR XI, IN HEALTHY SUBJECTS.

【24h】

POPULATION PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) MODELING FOR AN ANTISENSE OLIGONUCLEOTIDE (ISIS-FXIRx), TARGETING FACTOR XI, IN HEALTHY SUBJECTS.

机译：目标对象XI的健康人群中抗药性寡核苷酸（ISIS-FXIRx）的种群药动学/药动学（PK / PD）模型。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical Pharmacology and Therapeutics》 |2015年第s1期|共2页
作者
Yu R.; Luu K.; Bethune C.; Bhanot S.; Liu Q.; Wang Y.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. POPULATION PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) MODELING FOR AN ANTISENSE OLIGONUCLEOTIDE (ISIS-FXIRx), TARGETING FACTOR XI, IN HEALTHY SUBJECTS. [J] . Yu R., Luu K., Bethune C., Clinical Pharmacology and Therapeutics . 2015,第S1期

机译：目标对象XI的健康人群中抗药性寡核苷酸（ISIS-FXIRx）的种群药动学/药动学（PK / PD）模型。
2. POPULATION PHARMACOKINETIC-PHARMACODYNAMIC (PKPD) MODELING OF AMG 747, A GLYCINE TRANSPORTER TYPE 1 (GLYT 1) INHIBITOR, IN HEALTHY SUBJECTS. [J] . Chen J., Dias C., Bragasin M., Clinical Pharmacology and Therapeutics . 2015,第S1期

机译：健康受试者中AMG 747的种群药代动力学-药动学（PKPD）建模，一种糖类转运蛋白1型（Glyt 1）抑制剂。
3. POPULATION PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) MODELING OF PB2452, A MONOCLONAL ANTIBODY FRAGMENT BEING DEVELOPED AS A TICAGRELOR REVERSAL AGENT, IN HEALTHY VOLUNTEERS. [J] . Kathman S., Wheeler J., Arnold S., Clinical Pharmacology and Therapeutics . 2020,第S1期

机译：PB2452的群体药代动力学/药效学（PK / PD）模型，在健康志愿者中被开发为TiCagresor逆转剂的单克隆抗体片段。
4. FPGA Implementation of a Pharmacodynamic and Pharmacokinetics (PK/PD) Model for Application in General Anesthesia [C] . Maria Camila Cardona García, David Alejandro Vallejo Santacruz, Daniel Felipe Valencia Vargas, IEEE ANDESCON Conference . 2018

机译：用于全身麻醉的药效和药代动力学（PK / PD）模型的FPGA实现
5. Mechanism-based pharmacokinetic/pharmacodynamic PK/PD modeling of corticosteroids and antiretrovirals. [D] . Fang, Jing. 2012

机译：皮质类固醇和抗逆转录病毒药物的基于机理的药代动力学/药效动力学PK / PD建模。
6. 1321. Population Pharmacokinetic (PK) and Pharmacokinetic/Pharmacodynamic (PK/PD) Target Attainment Analyses for Dalbavancin in Pediatric Patients [O] . Timothy J Carrothers, H Maxime Lagraauw, Lars Lindbom, 2020

机译：1321.人口药代动力学（PK）和药代动力学/药效学（PK / PD）对儿科患者达尔巴维蛋白的目标达到分析
7. Population pharmacokinetic/pharmacodynamic (PK/PD) modeling of depot testosterone cypionate in healthy male subjects [O] . Bi, Youwei 2016

机译：健康男性受试者中睾丸激素睾丸酮药库的群体药代动力学/药效学（PK / PD）模型

POPULATION PHARMACOKINETIC/PHARMACODYNAMIC (PK/PD) MODELING FOR AN ANTISENSE OLIGONUCLEOTIDE (ISIS-FXIRx), TARGETING FACTOR XI, IN HEALTHY SUBJECTS.

著录项

相似文献

相关主题

期刊订阅